• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dynatronics Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    12/17/25 8:10:02 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care
    Get the next $DYNT alert in real time by email
    Dynatronics Corp.: Form 8-K - Filed by newsfilecorp.com

    false 2025-12-11 0000720875 Dynatronics Corp. 0000720875 2025-12-11 2025-12-11

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): December 11, 2025

    DYNATRONICS CORP.
    (Exact name of registrant as specified in its charter)

    Utah 000-12697 87-0398434
    (State or other jurisdiction (Commission (IRS Employer
    of incorporation) File Number) Identification No.)

    1200 Trapp Rd.
    Eagan, Minnesota, United States 55121
    (Address of principal executive offices) (ZIP Code)

    Registrant’s telephone number, including area code: (801) 568-7000

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14(d)-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(g) of the Act:

    Title of each class   Trading Symbols   Name of each exchange on which registered
    Common stock, no par value   DYNT   OTCQB

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


    ITEM 5.07 Submission of Matters to a Vote of Security Holders

    (a) On December 11, 2025, Dynatronics Corporation (the "Company") held its 2025 Annual Meeting of Shareholders (the "Annual Meeting"). As of the record date of October 10, 2025, shares eligible to vote totaled 16,574,050, comprised of 16,001,331 shares of Common Stock, 1,992,000 shares of Series A Preferred Stock (325,627 shares "as-converted" voting power), and 1,359,000 shares of Series B Preferred Stock (247,092 shares "as-converted" voting power). A quorum of 12,855,152 shares (77.56%) of the eligible shares of Common Stock were present in person or represented by proxy at the meeting.

    (b) The following is a brief description of each Proposal submitted to a vote at the Annual Meeting, as well as the final results for the votes cast with respect to each Proposal.

    Proposal No. 1: Election of Directors

    The shareholders elected each of R. Scott Ward, Andrew Hulett, and Brian D. Baker to serve until the 2026 Annual Meeting of Shareholders, and until their successors are duly elected and qualified or until their earlier death, resignation, retirement or removal, by the following vote:

      Votes For Withheld Broker Non-Votes
    R. Scott Ward 11,564,039 292,109 999,004
    Andrew Hulett 11,613,961 242,187 999,004
    Brian D. Baker 11,511,122 345,026 999,004

    Proposal No. 2: Ratification of the appointment of Tanner LLC as Independent Registered Public Accounting Firm for the Fiscal Year Ending June 30, 2026

    The shareholders ratified the selection of Tanner LLC as the Company's independent registered public accounting firm for its fiscal year ending June 30, 2026 by the following vote:

    Votes For Votes Against Abstentions
    12,807,676 35,734 11,742

    Proposal No. 3: Approval, on an advisory basis, of executive compensation.

    The shareholders approved, on an advisory basis, the compensation of the Company's named executed officers by the following vote:

    Votes For Votes Against Abstentions Broker Non-Votes
    11,537,491 316,595 2,062 999,004

    Proposal No. 4: To vote, on an advisory basis, on the frequency of holding future advisory votes on executive compensation.

    The shareholders approved, on an advisory basis, holding the advisory vote on the compensation of the Company's named executive officers every three years by the following vote:

    1 Year 2 Years 3 Years Abstentions Broker Non-Votes
    345,579 853 11,476,248 33,468 999,004

    No other items were presented for shareholder approval at the Annual Meeting.

    In light of the results of the shareholder vote on the frequency of future advisory votes on the compensation of the Company's named executive officers, and consistent with the Company's recommendation, the Company's Board of Directors has determined that the Company will hold an advisory vote on executive compensation every three years until the next required vote on the frequency of future advisory votes on the compensation of the Company's named executive officers.

    2


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: December 17, 2025 DYNATRONICS CORPORATION
         
      By:     /s/ Brian Baker
      Name: Brian Baker
      Title:    President & Chief Executive Officer

    3


    Get the next $DYNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DYNT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Essig Stuart acquired 16,095 shares, increasing direct ownership by 0.30% to 4,533,824 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 9:10:45 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Large owner Provco Ventures 1 Lp acquired 8,043 shares, increasing direct ownership by 0.29% to 2,739,998 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 9:10:25 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Director Enright Erin S. acquired 16,095 shares (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 8:04:18 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    SEC Filings

    View All

    Dynatronics Corporation filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    1/12/26 4:15:58 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    12/17/25 8:10:02 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Dynatronics Corporation

    10-Q - DYNATRONICS CORP (0000720875) (Filer)

    11/19/25 9:36:08 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Leadership Updates

    Live Leadership Updates

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/14/23 12:35:29 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/13/23 12:33:51 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    1/14/22 12:22:28 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Financials

    Live finance-specific insights

    View All

    Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

    Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

    5/11/23 7:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

    Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

    4/27/23 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

    EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

    2/9/23 7:30:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care